Shanghai Vitalgen Biopharma Co., Ltd.
Clinical trials sponsored by Shanghai Vitalgen Biopharma Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Gene therapy trial aims to tame Parkinson's symptoms Results expected Sep 2026 (estimated)
- Gene therapy injection aims to halt blindness from rare eye disorder Results expected Dec 2026 (estimated)
- Gene therapy takes on rare eye disease in Second-Eye trial Results expected Jul 2027 (estimated)
- New gene therapy trial hopes to tame rare metabolic disease in kids Results expected Aug 2027 (estimated)
- Gene therapy injection targets Parkinson's in patients with GBA1 mutations Results expected Sep 2027 (estimated)